Poseida Therapeutics: Global Collaboration Agreement With Roche
Poseida announced a strategic global collaboration agreement with Roche potentially worth up to $6 billion. See why I feel PSTX stock appears undervalued.
Source: seekingalpha.com
Stay updated with breaking news from Poseida Differentiated Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Poseida announced a strategic global collaboration agreement with Roche potentially worth up to $6 billion. See why I feel PSTX stock appears undervalued.